<DOC>
	<DOCNO>NCT02436122</DOCNO>
	<brief_summary>The effect preoperative glycemic control measure HbA1c prostate cancer ( PCa ) outcome remain controversial . Thus , investigator aim examine association preoperative glycemic control oncologic outcomes radical prostatectomy ( RP ) . The investigator prospectively collect relevant data include preoperative HbA1c 264 patient PCa patient undergo RP . The association clinical variable risk adverse pathological feature disease recurrence test use multivariate logistic regression multiple Cox-proportional hazard model , respectively .</brief_summary>
	<brief_title>Impact Preoperative HbA1c Levels Pathologic Features Oncological Outcomes Patients With Prostate Cancer</brief_title>
	<detailed_description>- This observational study single institutional , prospective cohort study . The investigator prospectively collect clinicopathological information patient prostate cancer ( PCa ) undergo radical prostatectomy ( RP ) . - Particularly , investigator check variable , include age surgery , body mass index , comorbidities , preoperative PSA level , prostate volume measure TRUS , preoperative HbA1c level , biopsy Gleason score , positive biopsy core , percent positive core , clinical TMN staging , final pathological result ( TMN stage , Gleason score , extraprostatic extension , seminal vesicle invasion , surgical margin positivity , postoperative biochemical recurrence ( BCR ) , local recurrence , distant metastasis follow-up period . - The study protocol routine follow-up schedule patient PCa treat RP . Typically , investigator check patient 1 , 3 , 6 , 9 , 12 , 18 , 24 , 30 36 month . However , accord patient status preference , follow-up schedule change within 3 month specific time point . Because present study observational cohort study , intervention study , subtle change follow-up schedule would affect primary outcome . - Importantly , preoperative HbA1c check within 1 month operation , routine preoperative laboratory test .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prostate cancer diagnose prostate biopsy Clinically localize PCa confirm prostate MRI Bone scan Patients undergo RP Distant metastasis , preoperatively Preoperative hormone therapy Preoperative chemotherapy Radiation therapy Medications affect glucose status diabetes mellitus</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Preoperative</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Hemoglobin A1c</keyword>
	<keyword>Pathologic outcome</keyword>
	<keyword>Oncological outcome</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Hemoglobin A1c Protein , Human</keyword>
</DOC>